Lyka Labs Limited Announces Impairment of Investment and Shares Consolidated Financials for FY26
Lyka Labs Limited announced key outcomes from its Board of Directors meeting held on May 25, 2026. The company reported the recognition of a significant impairment loss concerning its subsidiary, Lyka BDR International Limited, alongside presenting its audited financial results and financial statements for the quarter and year ended March 31, 2026.Impairment of Subsidiary Investment
The Board of Directors approved the recognition of an impairment loss in the value of the Company's investment and loans in its subsidiary, Lyka BDR International Limited (Lyka BDR). The impairment loss is quantified at Rs. 2301.44 Lakhs.The impairment charge was recorded due to continuous operational losses and severe erosion of the subsidiary's net worth. Lyka Labs Limited’s total financial exposure in Lyka BDR amounts to Rs. 2301.44 Lakhs. This figure includes an Equity Investment of Rs. 1469.05 Lakhs and an Unsecured Loan of Rs 832.39 Lakhs.
Audited Financial Performance
The company released its Audited Financial Results (Standalone and Consolidated) for the quarter and the full financial year ended March 31, 2026. The statutory auditors issued an unmodified opinion on the Standalone Financial Results for the year ended March 31, 2026.Key consolidated financial figures highlight the company's financial activity:
Statement of Consolidated Financial Results (in lakhs)
| Particulars | Quarter Ended 31st Mar, 2026 | Quarter Ended 31st Dec, 2025 | Quarter Ended 31st Mar, 2025 | Year Ended 31st Mar, 2026 | Year Ended 31st Mar, 2025 |
|---|---|---|---|---|---|
| Total Income | 2,864.19 | 3,189.02 | 3,424.88 | 13,194.24 | 14,072.71 |
| Total Expenses | 3,722.81 | 3,205.03 | 3,123.10 | 14,372.18 | 12,960.22 |
| Profit / (Loss) before Tax | (858.62) | (16.01) | 301.79 | (1,177.94) | 1,112.49 |
| Net Profit / (Loss) after Tax | (806.63) | (15-12) | 202.85 | (1,043.56) | 793.32 |
| Total Comprehensive Income / (Loss) | (819.18) | (16-97) | 220.94 | (1,057.96) | 811.41 |
Corporate Actions and Governance
In terms of corporate actions, the Board of Directors set Thursday, June 04, 2026, as the 'Record Date' for the Scheme of Amalgamation.The scheme mandates the allotment of 23 fully paid-up equity shares of the Transferee Company (Lyka Labs Limited), having a face value of Rs. 10/- each, for every 100 fully paid-up equity shares of Rs. 10/- each held by the eligible shareholders of the Transferor Company.
Additionally, the 47th Annual General Meeting of the Company is scheduled to be held on Monday, the 10th August, 2026, through the permission mode.
Financial Position Highlights
The company presented audited Standalone and Consolidated Statements of Assets and Liabilities as of March 31, 2026.Audited Consolidated Statement of Assets & Liabilities (in lakhs)
| Particulars | As at 31st March 2026 | As at 31st March, 2025 |
|---|---|---|
| TOTAL ASSETS | 17,453.64 | 17,620.20 |
| Non-Current Assets: | ||
| Property, Plant and Equipment | 8,040.07 | 7,689.84 |
| Capital Work-In-Progress | 185.66 | 20.14 |
| Intangible assets | 671.27 | 821.66 |
| Other Non Current Assets | 537.03 | 536.74 |
| Current Assets: | ||
| Inventories | 1,362.96 | 1,246.55 |
| Trade Receivables | 3,503.45 | 4,307.74 |
| Cash and Cash Equivalents | 135.91 | 134.41 |
| TOTAL EQUITY AND LIABILITIES | 17,453.64 | 17,620.20 |
| Equity: | ||
| Equity Share Capital | 3,569.00 | 3,569.00 |
| Other Equity | 5,670.35 | 6,905.00 |
| Total Liabilities: | ||
| Non-Current Liabilities (Total) | 2,980.58 | 2,599.30 |
| Current Liabilities (Total) | 5,389.92 | 4,662.71 |
Cash Flow from Operating Activities (Net Cash Flow)
| Period | For the Year Ended 31st March 2026 | For the Year Ended 31st March 2025 |
|---|---|---|
| Net Cash Flow from operating activities (A) | 524.28 | 189.94 |
| Net cash used in Investing activities (B) | (941.38) | (1,179.60) |
| Net cash flow from Financing activities (C) | (458.58) | N/A |
| Net increase / (decrease) in cash and cash equivalents (A+B+C) | (1,579.66) | (1,179.60) |
Note: Figures are presented in lakhs.
LYKALABS Stock Price Movement
Today, Lyka Labs Limited shares edged higher, closing at ₹62.00 after gaining 0.96%. The stock settled today amid moderate activity, recording a traded volume of 20,348 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: